v3.26.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY / (DEFICIT) - USD ($)
$ in Thousands
Ordinary shares
Additional paid-in capital
Accumulated other comprehensive loss gain / (loss)
Accumulated deficit
Total
Beginning balance at Dec. 31, 2024 $ 2,945 $ 1,173,068 $ (52,800) $ (1,129,965) $ (6,752)
Beginning balance (in shares) at Dec. 31, 2024 48,988,087        
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY / (DEFICIT)          
Loss for the period       (81,356) (81,356)
Other comprehensive gain (loss), net     (6,103)   (6,103)
Follow-on public offering $ 261 80,250     80,511
Follow-on public offering (in shares) 5,073,529        
Exercises of share options $ 1 202     203
Exercises of share options (in shares) 21,240        
Restricted and performance share units distributed during the period $ 43 (43)      
Restricted and performance share units distributed during the period (in shares) 782,817        
Share-based compensation expense   9,494     9,494
Ending balance at Jun. 30, 2025 $ 3,250 1,262,971 (58,903) (1,211,321) (4,003)
Ending balance (in shares) at Jun. 30, 2025 54,865,673        
Beginning balance at Mar. 31, 2025 $ 3,240 1,257,853 (53,805) (1,173,602) 33,686
Beginning balance (in shares) at Mar. 31, 2025 54,698,479        
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY / (DEFICIT)          
Loss for the period       (37,719) (37,719)
Other comprehensive gain (loss), net     (5,098)   (5,098)
Exercises of share options   44     44
Exercises of share options (in shares) 5,312        
Restricted and performance share units distributed during the period $ 10 (10)      
Restricted and performance share units distributed during the period (in shares) 161,882        
Share-based compensation expense   5,084     5,084
Ending balance at Jun. 30, 2025 $ 3,250 1,262,971 (58,903) (1,211,321) (4,003)
Ending balance (in shares) at Jun. 30, 2025 54,865,673        
Beginning balance at Dec. 31, 2025 $ 3,688 1,582,371 (58,222) (1,328,936) $ 198,901
Beginning balance (in shares) at Dec. 31, 2025 62,336,717       62,336,717
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY / (DEFICIT)          
Loss for the period       (134,594) $ (134,594)
Other comprehensive gain (loss), net     (29)   (29)
Follow-on public offering $ 323 242,359     242,681
Follow-on public offering (in shares) 5,686,813        
Exercises of share options $ 24 6,796     6,820
Exercises of share options (in shares) 410,849        
Restricted and performance share units distributed during the period $ 51 (51)      
Restricted and performance share units distributed during the period (in shares) 886,521        
Issuance of ordinary shares relating to employee stock purchase plan $ 1 164     165
Issuance of ordinary shares relating to employee stock purchase plan (in shares) 13,939        
Share-based compensation expense   10,106     10,106
Ending balance at Jun. 30, 2026 $ 4,086 1,841,745 (58,251) (1,463,530) $ 324,050
Ending balance (in shares) at Jun. 30, 2026 69,334,839       69,334,839
Beginning balance at Mar. 31, 2026 $ 3,728 1,587,971 (59,885) (1,382,471) $ 149,343
Beginning balance (in shares) at Mar. 31, 2026 63,033,249        
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY / (DEFICIT)          
Loss for the period       (81,059) (81,059)
Other comprehensive gain (loss), net     1,634   1,634
Follow-on public offering $ 323 242,359     242,681
Follow-on public offering (in shares) 5,686,813        
Exercises of share options $ 23 6,412     6,435
Exercises of share options (in shares) 385,541        
Restricted and performance share units distributed during the period $ 13 (13)      
Restricted and performance share units distributed during the period (in shares) 229,236        
Share-based compensation expense   5,016     5,016
Ending balance at Jun. 30, 2026 $ 4,086 $ 1,841,745 $ (58,251) $ (1,463,530) $ 324,050
Ending balance (in shares) at Jun. 30, 2026 69,334,839       69,334,839